Randomized phase 3 trial of irinotecan (CPT-11) + 5FU/folinic acid (FA) vs CDDP + 5FU in 1st-line advanced gastric cancer patients. ASCO Annual Meeting Proceedings 2005. - Dank,M.; Zaluski,J.; Barone,C. (J ClinOncol)